CN112213401B - 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 - Google Patents
一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 Download PDFInfo
- Publication number
- CN112213401B CN112213401B CN201910620749.9A CN201910620749A CN112213401B CN 112213401 B CN112213401 B CN 112213401B CN 201910620749 A CN201910620749 A CN 201910620749A CN 112213401 B CN112213401 B CN 112213401B
- Authority
- CN
- China
- Prior art keywords
- gly
- pro
- val
- arg
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 105
- 239000008273 gelatin Substances 0.000 title claims abstract description 105
- 229920000159 gelatin Polymers 0.000 title claims abstract description 105
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 105
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 105
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 23
- 241000283074 Equus asinus Species 0.000 title abstract description 18
- 102000007079 Peptide Fragments Human genes 0.000 claims abstract description 30
- 108010033276 Peptide Fragments Proteins 0.000 claims abstract description 30
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- 150000002500 ions Chemical class 0.000 claims description 34
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 claims description 27
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 24
- 238000001819 mass spectrum Methods 0.000 claims description 19
- 239000012071 phase Substances 0.000 claims description 18
- 238000004885 tandem mass spectrometry Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 14
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims description 13
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 12
- 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 claims description 12
- 108010052008 colla corii asini Proteins 0.000 claims description 12
- 235000019253 formic acid Nutrition 0.000 claims description 12
- 241000282994 Cervidae Species 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 238000001360 collision-induced dissociation Methods 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 239000007791 liquid phase Substances 0.000 claims description 6
- 238000011068 loading method Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 238000001228 spectrum Methods 0.000 claims description 6
- 108010019160 Pancreatin Proteins 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 5
- 229940055695 pancreatin Drugs 0.000 claims description 5
- 239000002243 precursor Substances 0.000 claims description 5
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 3
- 238000011033 desalting Methods 0.000 claims description 3
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 claims description 2
- 238000000861 blow drying Methods 0.000 claims description 2
- 241000283898 Ovis Species 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 230000037427 ion transport Effects 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 5
- 238000001514 detection method Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000003908 quality control method Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 24
- 239000000523 sample Substances 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 241000283073 Equus caballus Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241001331845 Equus asinus x caballus Species 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710118538 Protease Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000006240 deamidation Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- SCAKQYSGEIHPLV-IUCAKERBSA-N (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-(carboxymethylcarbamoyl)pyrrolidin-1-yl]-5-oxopentanoic acid Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SCAKQYSGEIHPLV-IUCAKERBSA-N 0.000 description 1
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 1
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 1
- HJARVELKOSZUEW-YUMQZZPRSA-N Gly-Pro-Gln Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJARVELKOSZUEW-YUMQZZPRSA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007379 Muscle Hypotonia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 1
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010025801 glycyl-prolyl-arginine Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8696—Details of Software
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/067—Preparation by reaction, e.g. derivatising the sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了一种用于鉴别阿胶及其制品的驴源性特征肽,所述的肽段包括肽段一:HGNRGEPGPVGSVGPVGAVGPRGPSGPQGVRGDK和/或肽段二:GPTGEPGK。本发明通过大量实验筛选得到两条驴源性特征肽段,这两条特征肽段具有很高的专属性,可用于鉴定驴皮、阿胶及阿胶制品。并且本发明提供的阿胶及其制品的鉴别方法,通过大量实验筛选出最佳的色谱条件和质谱条件,整个方法操作简单,准确性高,有利于阿胶的质量控制,可大大提高阿胶及其产品的检测效率和准确度,对保证阿胶及其制品的质量具有重要的意义。
Description
技术领域
本发明属于医药与食品检测技术领域,具体涉及阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法。
背景技术
阿胶(Asini Corii Colla)为马科动物驴Equus asinus L.的干燥皮或鲜皮经煎煮、浓缩制成的固体胶。阿胶具补血滋阴,润燥,止血之功。用于血虚萎黄,眩晕心悸,肌痿无力,心烦不眠,虚风内动,肺燥咳嗽,劳嗽咯血,吐血尿血,便血崩漏,妊娠胎漏。《本草纲目》载:“阿胶《本经》上品。弘景曰:‘出东阿,故名阿胶’”。道地阿胶表面平整,无油气孔,质硬而脆,断面光亮细腻,碎片对光照视呈棕色半透明状,李时珍赞其“黄透如琥珀色,光黑如瑿漆”。
在现有市场上存在假阿胶、伪劣阿胶,并以次充好向市场销售,严重影响了广大人民群众的饮食和用药安全。
目前不法企业常以马皮、牛皮、猪皮等掺杂制备阿胶来以次充好,导致阿胶造假事件屡禁不止的原因之一是缺少简单、可行、准确的鉴定技术支持,动物皮经过熬制后,很难鉴别出动物皮的来源。因此,寻找专属性、准确高的方法来鉴定阿胶及其制品真伪意义重大。
发明内容
发明目的:本发明基于阿胶与其它多种伪品胶的多肽成分对比分析,从中筛选辨识两个阿胶特征肽段,并建立以液相色谱-串连质谱技术进行阿胶真伪鉴别的方法。本发明可填补阿胶及其制品真伪鉴别的空白,为保证阿胶及其制品的质量提供科学方法。
技术方案:为了实现以上目的,本发明采取的技术方案为:
一种用于鉴别阿胶及其制品的驴源性特征肽,其所述的特征肽序列为:
肽段一:
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pr o-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或肽段二:Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys。
作为优选方案,以上所述的用于鉴别阿胶及其制品的驴源性特征肽,其中脯氨酸Pro可被羟基化形成羟脯氨酸Hyp。
作为优选方案,以上所述的用于鉴别阿胶及其制品的特征肽,其中天门冬酰胺Asn及谷氨酰胺Gln可被脱酰胺化分别形成天冬氨酸Asp及谷氨酸Glu。
一种阿胶及其制品的鉴别方法,其包括以下步骤:
(1)以缓冲液或水溶解待测的阿胶及阿胶制品,加入1%~5%的蛋白内切酶LysC在37℃酶解12-18小时,获得多肽溶液,多肽溶液脱盐后浓缩干燥;
(2)采用LC-MS/MS检测,流动相A相为3%乙腈水溶液,其中含0.1%三氟乙酸,流动相B相为80%乙腈水溶液,其中含0.1%三氟乙酸,梯度洗脱,100min,0%流动相B→30%流动相B;
(3)质谱扫描范围:100-2000Da,正离子模式,选择多电荷进行二级质谱分析;
(4)对获得的MS/MS图谱,采用搜库软件进行分析,自建蛋白质数据库,自建蛋白质数据库中包含除了以上所述的两条驴源性特征肽的信息外,还包含猪、牛、马、鹿动物的同源肽段信息;
(5)搜库参数中PTM的设置包括:羟基化,脱酰胺化和氧化
(6)根据搜库结果作出判断:
搜库结果中
a.样品搜库结果有且仅有驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys的信息,则为驴源性正品;
b、样品搜库结果未见驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys的信息,则为伪品;
c、样品搜库结果有驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys的信息,且有其它动物猪、牛、马、鹿的同源肽段信息,则为掺杂样品。
一种阿胶及其制品的鉴别方法,其包括以下步骤:
(1)阿胶对照溶液的制备:取阿胶对照药材,加pH值为7~8的缓冲溶液溶解,经蛋白内切酶LysC酶解,然后经Seppak C18脱盐处理,制备得到阿胶对照药材溶液;
(2)待检测样品溶液的制备:取待测阿胶或阿胶制品,按照步骤(1)相同的方法,制备得到待检测样品溶液;
(3)将步骤(1)和(2)得到的鹿胶对照溶液及待测样品溶液,采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
(4)将获得的MS/MS图谱,采用搜库软件(Peaks 8.5软件)进行分析,自建蛋白质数据库,自建数据库中包含除了两条驴源性特征肽段的信息外,还可包含猪、牛、马、鹿等动物的同源肽段信息;
(5)自建的蛋白质数据库如下:
>Deer_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Cattle_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Pig_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys
>Sheep_Peptide_1
His-Gly-Ser-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Deer_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Cattle_Peptide_2
Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Pig_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Sheep_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
(6)搜库参数中PTM的设置包括:羟基化,脱酰胺化和氧化;
(7)根据搜库结果作出判断:
搜库结果中
a.如果有且仅有驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys,则为阿胶制品;
b.如果除了驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys外,还含有其它任何肽段,则为掺假阿胶样品;
c.如果未检测到驴源来源的肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys和/或Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys,则为阿胶伪品。
作为优选方案,以上所述的阿胶及其制品的前处理方法为LysC蛋白酶进行酶切,由于LysC选择性的切断赖氨酸(Lys,K)后面的酰胺键,与胰蛋白酶选择性切断精氨酸(Arg,R)与赖氨酸(Lys,K)后面的酰胺键不同,本发明通过实验发现,采用LysC蛋白酶进行酶切,才可获得更具有专属性的肽段,可用于鉴别与区分阿胶及其制品。
作为优选方案,以上所述的阿胶及其制品的鉴别方法,步骤(3)的色谱条件为:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5μm Reprosil C18AQ,规格为75μm×150mm,上样量为2μg,流速300nL/min,流动相A为体积比为2:0.2:98的乙腈/甲酸/水,流动相B为体积比为80/0.2/20的乙腈/甲酸/水,0~150min,2~30%B线性梯度洗脱;
质谱条件为:喷雾电压为2.5kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离二级串联质谱。
本发明所述的阿胶及其制品的鉴别方法,所述的阿胶制品包括:阿胶膏、阿胶糕、阿胶口服液、阿胶浆、阿胶颗粒。
本发明所述的阿胶及其制品的鉴别方法,阿胶伪品包括驴皮、马皮、猪皮、牛皮、鹿皮、羊皮等。
有益效果:本发明通过大量实验筛选,筛选出两条驴源性特征肽段,这两条特征肽段具有很高的专属性,可用于鉴定驴皮、阿胶及阿胶制品。
本发明提供的阿胶及其制品的鉴别方法,通过大量实验筛选出最佳的色谱条件和质谱条件。整个方法操作简单,判断准确,能准确区分阿胶与马皮胶。本发明提供的肽段序列及技术方法有利于阿胶的质量控制,且可鉴别市场上的各类阿胶制品,可大大提高阿胶及其产品的检测效率和准确度,对保证阿胶及其制品的质量具有重要的意义。
附图说明
图1为本发明提供的用于鉴别阿胶及其制品的驴源性特征肽的质谱图。
具体实施方式
下面结合具体实施例进一步阐明本发明,应理解这些实施例仅用于说明本发明而不用于限制本发明的范围,在阅读了本发明之后,本领域技术人员对本发明的各种等价形式的修改均落于本申请所附权利要求所限定的范围。
实施例1:阿胶、马皮胶、黄明胶(牛皮胶)、新阿胶(猪皮胶)、鹿皮胶、羊皮胶的鉴别
(1)收集阿胶、马皮胶、黄明胶(牛皮胶)、新阿胶(猪皮胶)、鹿皮胶和羊皮胶,取各种胶类药材粉末0.1g,置于50ml锥形瓶中加入1% NH4HCO3溶液定容至刻度,使其溶解,配制LysC蛋白酶溶液(LysC酶100μg用Resuspension Buffer 1ml重新溶解),取胶类药液200μl加入配制好的LysC蛋白酶溶液20μl,37℃酶解12h,加入10%三氟乙酸溶液10μl进行灭活,离心(10000r/min),用Seppak C18固相萃取脱盐,样品液氮气吹干,加水溶解,备用。
(2)然后采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
Nano LC-MS/MS条件:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5μm Reprosil C18AQ(75μm×150mm),上样量为2μg,流速300nL/min,流动相A(乙腈/甲酸/水=2/0.2/98,v/v/v),流动相B(乙腈/甲酸/水=80/0.2/20,v/v/v),2~30%B线性梯度洗脱150min。
质谱条件为:喷雾电压为2.5kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离(CID)二级串联质谱。
选择自建数据库搜索,数据库中包含:
>Deer_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Cattle_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Pig_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys
>Sheep_Peptide_1
His-Gly-Ser-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Deer_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Cattle_Peptide_2
Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Pig_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Sheep_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
检索参数设置为:前体离子误差20ppm;子离子误差0.2Da;允许2个位点误切,假阳性率(FDR)≤1%;酶切方式选择胰酶(LysC),唯一肽段数(unique peptides)≥2;其它参数为默认参数,在上述检索条件下所得分值有显著性意义(P<0.05)被认定为有效的鉴定结果。
结果阿胶样品中仅鉴定出专属肽段His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys(质谱图如图1所示)与Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys,马皮胶中仅鉴定出肽段His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys。
鹿皮胶中鉴定出His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys,牛皮胶中鉴定出His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys,羊皮胶中鉴定出His-Gly-Ser-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys,猪皮胶中鉴定出His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys,通过本发明的方法可准确鉴定出阿胶。
实施例2:马皮掺假阿胶的鉴别
(1)将马皮胶以不同比例掺入到阿胶中(1:99、20:80、50:50),取掺假阿胶样品粉末0.1g,置于50ml锥形瓶中加入1% NH4HCO3溶液定容至刻度,使其溶解,配制LysC蛋白酶溶液(LysC酶100μg用Resuspension Buffer 1ml重新溶解),取胶类药液200μl加入配制好的LysC蛋白酶溶液20μl,37℃酶解12h,加入10%三氟乙酸溶液10μl进行灭活,离心(10000r/min),用Seppak C18固相萃取脱盐,样品液氮气吹干,加水溶解,备用。
(2)然后采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
Nano LC-MS/MS条件:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5μm Reprosil C18AQ(75μm×150mm),上样量为2μg,流速300nL/min,流动相A(乙腈/甲酸/水=2/0.2/98,v/v/v),流动相B(乙腈/甲酸/水=80/0.2/20,v/v/v),2~30%B线性梯度洗脱150min。
质谱条件为:喷雾电压为2.5kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离(CID)二级串联质谱。
选择自建数据库搜索,数据库中包含:
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
检索参数设置为:前体离子误差20ppm;子离子误差0.2Da;允许2个位点误切,假阳性率(FDR)≤1%;酶切方式选择胰酶(LysC),唯一肽段数(unique peptides)≥2;其它参数为默认参数,在上述检索条件下所得分值有显著性意义(P<0.05)被认定为有效的鉴定结果。
掺假的阿胶样品中除了检测到阿胶的专属肽段外,均检测到马皮的专属性肽段His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys,表明本发明方法可检验有马皮掺假的阿胶样品,掺假量为1%即可检出。
实施例3:以骡子皮为原料制备的阿胶伪品(骡皮胶)的鉴别
(1)取骡皮胶样品粉末0.1g,置于50ml锥形瓶中加入1% NH4HCO3溶液定容至刻度,使其溶解,配制LysC蛋白酶溶液(LysC酶100μg用Resuspension Buffer 1ml重新溶解),取胶类药液200μl加入配制好的LysC蛋白酶溶液20μl,37℃酶解12h,加入10%三氟乙酸溶液10μl进行灭活,离心(10000r/min),用Seppak C18固相萃取脱盐,样品液氮气吹干,加水溶解,备用。
(2)然后采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
Nano LC-MS/MS条件:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5μm Reprosil C18AQ(75μm×150mm),上样量为2μg,流速300nL/min,流动相A(乙腈/甲酸/水=2/0.2/98,v/v/v),流动相B(乙腈/甲酸/水=80/0.2/20,v/v/v),2~30%B线性梯度洗脱150min。
质谱条件为:喷雾电压为2.5kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离(CID)二级串联质谱。
选择自建数据库搜索,数据库中包含:
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
检索参数设置为:前体离子误差20ppm;子离子误差0.2Da;允许2个位点误切,假阳性率(FDR)≤1%;酶切方式选择胰酶(LysC),唯一肽段数(unique peptides)≥2;其它参数为默认参数,在上述检索条件下所得分值有显著性意义(P<0.05)被认定为有效的鉴定结果。
从骡子皮制备的阿胶伪品中同时检测到了马皮与驴皮的专属性肽段His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys,表明以骡皮制备阿胶伪品,或以骡皮掺假阿胶制品,其中可检测出马皮的专属性肽段,即可认为被测样品为非阿胶及其制品。
实施例4:多种动物皮掺假阿胶的鉴别
(1)将马皮胶、牛皮胶、鹿皮胶、猪皮胶与阿胶等比例掺到一起,取掺假阿胶样品粉末0.1g,置于50ml锥形瓶中加入1% NH4HCO3溶液定容至刻度,使其溶解,配制LysC蛋白酶溶液(LysC酶100μg用Resuspension Buffer 1ml重新溶解),取胶类药液200μl加入配制好的LysC蛋白酶溶液20μl,37℃酶解12h,加入10%三氟乙酸溶液10μl进行灭活,离心(10000r/min),用C18固相萃取脱盐,样品液氮气吹干,加水溶解,备用。
(2)然后采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
Nano LC-MS/MS条件:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5μm Reprosil C18AQ(75μm×150mm),上样量为2μg,流速300nL/min,流动相A(乙腈/甲酸/水=2/0.2/98,v/v/v),流动相B(乙腈/甲酸/水=80/0.2/20,v/v/v),2~30%B线性梯度洗脱150min。
质谱条件为:喷雾电压为2.5kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离(CID)二级串联质谱。
选择自建数据库搜索,数据库中包含:
>Deer_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Cattle_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Pig_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ar g-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Deer_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Cattle_Peptide_2
Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Pig_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
检索参数设置为:前体离子误差20ppm;子离子误差0.2Da;允许2个位点误切,假阳性率(FDR)≤1%;酶切方式选择胰酶(LysC),唯一肽段数(unique peptides)≥2;其他参数为默认参数,在上述检索条件下所得分值有显著性意义(P<0.05)被认定为有效的鉴定结果。
掺假的阿胶样品中除了检测到阿胶的专属肽段(His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys)外,还检测到马皮胶的专属肽段His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys,以及其它动物皮的肽段。表明本发明的鉴别方法,不仅可用于检测马皮掺杂阿胶,还可检测多种动物皮掺假的阿胶样品。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
序列表
<110> 南京中医药大学
<120> 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 34
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 1
His Gly Asn Arg Gly Glu Pro Gly Pro Val Gly Ser Val Gly Pro Val
1 5 10 15
Gly Ala Val Gly Pro Arg Gly Pro Ser Gly Pro Gln Gly Val Arg Gly
20 25 30
Asp Lys
<210> 2
<211> 8
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Gly Pro Thr Gly Glu Pro Gly Lys
1 5
Claims (1)
1.一种阿胶及其制品的鉴别方法,其特征在于,包括以下步骤:
(1)收集阿胶、马皮胶、牛皮胶、猪皮胶、鹿皮胶和羊皮胶,取各种胶类药材粉末0.1g,置于50ml锥形瓶中加入1% NH4HCO3溶液定容至刻度,使其溶解,将LysC酶100μg用Resuspension Buffer 1ml重新溶解,配制成LysC蛋白酶溶液;取以上各胶类药液200μl加入配制好的LysC蛋白酶溶液20μl,37℃酶解12h,加入10%三氟乙酸溶液10μl进行灭活,10000 r/min离心,用Seppak C18固相萃取脱盐,样品液氮气吹干,加水溶解,备用;
(2)然后采用液相色谱-串连质谱法,以电喷雾正离子模式扫描,对带电荷大于2的肽段进行二级质谱扫描,获得MS/MS图谱;
Nano LC-MS/MS条件:
戴安U3000 NanoRSLC纳升液相系统,色谱柱为5 μm Reprosil C18AQ,规格75μm ×150 mm,上样量为2μg,流速300 nL/min,流动相A相为体积比2:0.2:98的乙腈/甲酸/水,流动相B为体积比80/0.2/20的乙腈/甲酸/水,2~30%B线性梯度洗脱150 min;
质谱条件为:喷雾电压为2.5 kV,离子传输毛细管温度为200℃;质谱一级全扫描范围为m/z 300~2000,分离宽度为3 Da;串联质谱分析采用一级质谱数据依赖的二级质谱扫描模式,依次选取一级质谱中离子强度最高的5个离子进行碰撞诱导解离二级串联质谱;
选择自建数据库搜索,数据库中包含:
>Deer_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Cattle_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Donkey_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Pig_Peptide_1
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys
>Sheep_Peptide_1
His-Gly-Ser-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys
>Horse_Peptide_1
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys
>Deer_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Cattle_Peptide_2
Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys
>Donkey_Peptide_2
Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys
>Pig_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Sheep_Peptide_2
Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys
>Horse_Peptide_2
Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys
检索参数设置为:前体离子误差20 ppm;子离子误差0.2 Da;允许2个位点误切,假阳性率≤1%;酶切方式选择胰酶LysC,唯一肽段数≥2;
阿胶样品中仅鉴定出专属肽段:
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Glu-Pro-Gly-Lys;
马皮胶中仅鉴定出肽段:
His-Gly-His-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ser-Val-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Val-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Glu-Pro-Gly-Lys;
鹿皮胶中鉴定出肽段:
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys;
牛皮胶中鉴定出肽段:
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Ser-Gly-Asp-Pro-Gly-Lys;
羊皮胶中鉴定出肽段:
His-Gly-Ser-Arg-Gly-Glu-Pro-Gly-Pro-Val-Gly-Ala-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Asp-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys;
猪皮胶中鉴定出肽段:
His-Gly-Asn-Arg-Gly-Glu-Pro-Gly-Pro-Ala-Gly-Ser-Val-Gly-Pro-Ala-Gly-Ala-Val-Gly-Pro-Arg-Gly-Pro-Ser-Gly-Pro-Gln-Gly-Ile-Arg-Gly-Glu-Lys与Gly-Pro-Thr-Gly-Asp-Pro-Gly-Lys。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910620749.9A CN112213401B (zh) | 2019-07-10 | 2019-07-10 | 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 |
PCT/CN2019/117384 WO2021003926A1 (zh) | 2019-07-10 | 2019-11-12 | 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910620749.9A CN112213401B (zh) | 2019-07-10 | 2019-07-10 | 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112213401A CN112213401A (zh) | 2021-01-12 |
CN112213401B true CN112213401B (zh) | 2023-06-16 |
Family
ID=74047474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910620749.9A Active CN112213401B (zh) | 2019-07-10 | 2019-07-10 | 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112213401B (zh) |
WO (1) | WO2021003926A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109010371A (zh) * | 2018-08-17 | 2018-12-18 | 药圣堂(湖南)制药有限公司 | 一种阿胶口服制剂及其制备方法 |
CN114720601B (zh) * | 2022-04-12 | 2023-09-08 | 中国海洋大学 | 三条特征性肽段及其应用 |
CN115015409A (zh) * | 2022-05-23 | 2022-09-06 | 山东省食品药品检验研究院 | 一种阿胶多肽lcms特征图谱的建立方法及其质量评价方法 |
CN115669944A (zh) * | 2022-09-09 | 2023-02-03 | 东阿阿胶保健品有限公司 | 一种阿胶低聚肽在亮白肤色中的应用 |
CN115496760B (zh) * | 2022-11-17 | 2023-04-07 | 澳润(山东)药业有限公司 | 一种阿胶品质鉴定方法 |
CN115792243A (zh) * | 2022-11-25 | 2023-03-14 | 北京同仁堂(辽宁)科技药业有限公司 | 一种利用专属离子对检测鹿胶的方法及应用 |
CN116675761B (zh) * | 2023-04-10 | 2024-02-27 | 山东省食品药品检验研究院 | 绒促性素特征多肽组及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105301165B (zh) * | 2015-10-09 | 2018-01-12 | 东阿阿胶股份有限公司 | 一种驴特征性多肽及其在检测驴皮源性成分中的应用 |
CN106841437B (zh) * | 2017-01-20 | 2019-12-03 | 东阿阿胶股份有限公司 | 用于检测阿胶中驴皮源成分含量的组合物、试剂盒及其检测方法 |
CN109142598B (zh) * | 2018-09-10 | 2021-07-30 | 上海市食品药品检验研究院 | 一组驴源性特征肽和一种鉴定阿胶或阿胶制品的方法 |
CN109187835B (zh) * | 2018-09-17 | 2021-03-23 | 南京中医药大学 | 一种含蛋白质类中药的专属性肽段的鉴别方法 |
-
2019
- 2019-07-10 CN CN201910620749.9A patent/CN112213401B/zh active Active
- 2019-11-12 WO PCT/CN2019/117384 patent/WO2021003926A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021003926A9 (zh) | 2021-02-18 |
WO2021003926A1 (zh) | 2021-01-14 |
CN112213401A (zh) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112213401B (zh) | 一种阿胶及其制品的驴源性特征肽及其阿胶及其制品的鉴别方法 | |
CN109187835B (zh) | 一种含蛋白质类中药的专属性肽段的鉴别方法 | |
CN111239302B (zh) | 一种利用蛋白质内切酶切割胶原蛋白获得专属性肽段的方法和应用 | |
CN111825746B (zh) | 一组用于鉴别阿胶及阿胶制品中牛源性成分的多肽 | |
CN109187783B (zh) | 鹿胶特征肽及鉴定待测样品中是否包含鹿胶的方法 | |
CN105301165B (zh) | 一种驴特征性多肽及其在检测驴皮源性成分中的应用 | |
CN109280077B (zh) | 一种鉴别阿胶及含阿胶制品中猪皮源性成分的多肽 | |
CN109142598B (zh) | 一组驴源性特征肽和一种鉴定阿胶或阿胶制品的方法 | |
EP3336537B1 (en) | Method for identifying animal skin/hide | |
CN113480599A (zh) | 一种鉴别梅花鹿或马鹿鹿角胶的特征多肽及其应用 | |
CN106093244A (zh) | 一种羊特征性多肽及其应用 | |
CN103630620A (zh) | 一种胶类中药及其制品中鹿源性成分的检测方法 | |
CN111077215A (zh) | 质谱检测乳样品A1和A2β酪蛋白的方法 | |
CN107014957B (zh) | 一种利用气味成分快速判别驴皮质量的方法 | |
CN114113381B (zh) | 一种舒氏海龙特征多肽及其应用和鉴别舒适海龙的方法 | |
CN111077214A (zh) | 质谱检测乳制品中A1、A2型β酪蛋白的质谱模型及其构建方法 | |
Karongo et al. | Rapid enantioselective amino acid analysis by ultra-high performance liquid chromatography-mass spectrometry combining 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivatization with core-shell quinine carbamate anion exchanger separation | |
Cai et al. | Collagen derived species-specific peptides for distinguishing donkey-hide gelatin (Asini Corii Colla) | |
CN116143874B (zh) | 一种鉴别梅花鹿或马鹿源特征多肽及其应用 | |
CN108132180B (zh) | 一种磷酸化肽段富集试剂盒及富集方法 | |
CN109293741B (zh) | 一种鉴别阿胶及含阿胶制品中马皮源性成分的多肽 | |
CN115894613A (zh) | 鹿胶特征肽及其在鹿胶制品鉴别中的应用 | |
CN109293742B (zh) | 一种鉴别阿胶及含阿胶制品中骡皮源性成分的多肽 | |
CN115248277B (zh) | 刁海龙特征多肽及其应用和鉴别刁海龙的方法 | |
CN116462749B (zh) | 促肝细胞生长素特征多肽组及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |